The global pulse oximeter market was USD 3.76 Billion in 2025 and may reach USD 5.52 Billion by 2031 (CAGR 6.78%), driven by tech upgrades.
The pulse oximeter market is witnessing sustained growth driven by rising demand for continuous oxygen saturation monitoring, an increase in chronic respiratory conditions, and heightened public health focus following global respiratory outbreaks. The growing awareness among consumers and healthcare providers about early detection of hypoxemia and the importance of monitoring oxygen levels in both clinical and home settings has significantly contributed to adoption. Miniaturization of devices, integration of Bluetooth connectivity, and advancements in sensor accuracy are expanding the market appeal across medical and wellness segments. Healthcare infrastructure improvements in emerging economies and increased government emphasis on patient safety protocols are also reinforcing the demand for these noninvasive monitoring tools. As healthcare delivery evolves toward home based and remote care, the outlook for pulse oximeters remains positive, supported by technological innovation and expanding clinical utility. The rising prevalence of specific disorders like asthma, hyperlipidemia, high blood pressure, diabetes, ischemic conditions, cardiac arrhythmia, sleep apnea, and COPD is expected to further drive the market. The WHO estimates that 64 million people globally suffer from COPD and that 90% of COPD deaths take place in low- and middle-income nations. The rise in chronic diseases such as cancer (currently there are more than 200 types of cancer in the world), diabetes, heart disease, and other diseases, is expected to drive the adoption of the pulse oximeter market. Globally, chronic illness and disease are on the rise. According to the research report "Global Pulse Oximeter Market Outlook, 2031," published by Bonafide Research, the Global Pulse Oximeter market was valued at more than USD 3.76 Billion in 2025, and expected to reach a market size of more than USD 5.52 Billion by 2031 with the CAGR of 6.78% from 2026-2031. Technological advancements in pulse oximeters have made them more accurate and cost-effective, driving market demand. Traditional pulse oximeters use transmittance technology, where light passes through tissue. In contrast, reflectance pulse oximetry measures light reflected from tissue, allowing more flexible placement, including on the forehead and chest, which is particularly useful for patients with poor peripheral circulation. For instance, in March 2023, OxiWear, a U.S.-based health technology startup, launched a wireless, ear-mounted pulse oximeter designed to continuously monitor oxygen levels and notify users of low oxygen. Equipped with an optical sensor and Bluetooth LE technology, it transmits health metrics to a smartphone app. In addition, it provides data on SpO2 levels and heart rate and allows users to specify emergency contacts. The increasing incidence of respiratory disorders, fueled by factors such as overconsumption of alcohol & tobacco, sedentary lifestyles, unhealthy diets, and obesity, is expected to drive demand for technologically advanced pulse oximeters. For instance, statistics from the American College of Allergy, Asthma & Immunology in June 2023, indicate that approximately 7.7% of Americans suffer from asthma. Furthermore, the following figure depicts the projected proportion of deaths attributed to leading respiratory causes, highlighting the critical need for advanced monitoring technologies in healthcare settings.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Product Type | Fingertip Pulse Oximeters | |
| Hand-held Pulse Oximeters | ||
| Wrist-worn Pulse Oximeters | ||
| Table-top/Bedside Pulse Oximeters | ||
| By End-user | Hospitals and clinics | |
| Homecare | ||
| Others | ||
| By Age group | Pediatrics | |
| Adults | ||
| By Types | Potable Pulse Oximeter | |
| Bedside/Table topper | ||
| By Technology | Conventional | |
| Connected | ||
| By End User | Hospitals & Clinics | |
| Home Health care | ||
| Others end user | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Portable pulse oximeters dominate the global pulse oximeter market because their convenience affordability and suitability for both clinical and home use make them the most widely adopted and versatile monitoring solution. With the global rise in chronic respiratory and cardiovascular diseases along with aging populations there is a growing need for continuous and frequent monitoring of blood oxygen levels outside traditional hospital infrastructure. Portable pulse oximeters meet this need effectively by allowing patients to monitor their oxygen saturation anytime without requiring professional assistance or complex setup. The expansion of home healthcare services and the growing preference for self-monitoring and preventive care have further increased demand for portable devices since they empower patients to actively manage their health while reducing hospital visits and healthcare costs. In addition affordability plays a crucial role as portable pulse oximeters are generally more cost effective than tabletop or integrated hospital systems which make them accessible to a wider population including those in developing and resource limited regions. Their lower price point combined with acceptable accuracy for routine monitoring has encouraged large scale adoption by individual consumers as well as healthcare providers. The impact of the COVID pandemic also significantly accelerated the dominance of portable pulse oximeters as oxygen saturation monitoring became a critical tool for early detection of respiratory deterioration and patients were advised to monitor their levels at home. This period created lasting awareness and behavioral change among consumers reinforcing the importance of owning personal monitoring devices. Technological advancements have also strengthened the market position of portable pulse oximeters as improvements in sensor accuracy battery life and digital displays have enhanced performance and user experience. Many modern portable oximeters now offer features such as quick readings memory storage and connectivity with smartphones which aligns with the global trend toward digital health and remote patient monitoring. Conventional pulse oximetry technology dominates the global pulse oximeter market because it is clinically proven widely accepted cost effective and trusted for accurate routine oxygen saturation monitoring across healthcare settings. Healthcare professionals across the world are extensively trained in the use and interpretation of conventional pulse oximetry readings which reinforces confidence and continued reliance on this technology. Because of its proven accuracy in routine monitoring conditions conventional pulse oximetry is deeply embedded in clinical protocols for anesthesia intensive care emergency medicine post-operative care and general patient monitoring. Hospitals and clinics prefer technologies that are well validated and supported by regulatory approvals and clinical guidelines and conventional pulse oximetry meets these requirements effectively. Another key factor supporting its dominance is cost efficiency as conventional pulse oximetry systems are generally less expensive to manufacture and purchase compared to advanced or emerging technologies. This affordability enables widespread deployment across large healthcare facilities as well as smaller clinics and resource constrained settings especially in developing regions where budget limitations strongly influence purchasing decisions. In addition conventional pulse oximeters are compatible with a wide range of device formats including bedside monitors handheld devices and portable fingertip models which increases their market penetration across multiple product categories. Their simplicity and ease of maintenance further enhance their appeal as they require minimal calibration limited technical support and have low operational complexity. From a regulatory and reimbursement perspective conventional pulse oximetry benefits from established approval pathways and inclusion in standard healthcare reimbursement frameworks which encourages hospitals to continue investing in these systems rather than transitioning to newer less familiar technologies. Pediatrics represents the largest age group segment in the global pulse oximeter market because children especially infants require continuous and frequent oxygen monitoring due to higher vulnerability to respiratory conditions and clinical complications. Pediatric patients have underdeveloped respiratory and immune systems which makes them more susceptible to respiratory infections congenital heart diseases asthma pneumonia bronchitis and neonatal complications such as respiratory distress syndrome and low birth weight related hypoxia. As a result pulse oximetry becomes a critical and routine tool in pediatric care settings including neonatal intensive care units pediatric intensive care units emergency departments and general pediatric wards. In newborn care pulse oximeters are widely used for early screening of congenital heart defects and for monitoring premature infants who often need continuous oxygen assessment to prevent complications such as hypoxemia or oxygen toxicity. The high global birth rate particularly in developing countries contributes to a consistently large pediatric patient pool which directly drives demand for pediatric pulse oximeters. In addition childhood respiratory illnesses remain one of the leading causes of hospital visits and admissions worldwide which further increases usage of pulse oximeters in pediatric populations. Healthcare providers prioritize noninvasive and painless monitoring methods for children and pulse oximetry perfectly meets this requirement making it the preferred technology for oxygen monitoring in this age group. The growing emphasis on early diagnosis and preventive pediatric care has also expanded the use of pulse oximeters beyond hospitals into primary care clinics and community health programs. Governments and international health organizations actively promote the use of pulse oximetry in maternal and child health initiatives to reduce infant and child mortality particularly in low and middle income regions. Hospitals and clinics dominate the global pulse oximeter market because they are the primary centers for diagnosis treatment surgery and continuous patient monitoring requiring high and repeated use of pulse oximetry devices. Pulse oximeters are a standard and indispensable tool in hospitals and clinics for monitoring patients during surgery anesthesia post-operative recovery and critical care as even minor fluctuations in oxygen levels can have serious clinical consequences. The increasing burden of chronic diseases such as cardiovascular disorders respiratory illnesses diabetes and kidney disease has significantly raised hospital admissions and outpatient visits which directly increases the demand for pulse oximeters in these settings. Hospitals also handle severe and complex cases including trauma infections and respiratory failure where continuous and accurate oxygen monitoring is mandatory making pulse oximeters a core component of patient management protocols. Clinics particularly specialty and multispecialty clinics use pulse oximeters extensively for routine examinations early diagnosis and follow up care especially in pulmonology cardiology pediatrics and primary care. Another key factor driving dominance is the availability of skilled healthcare professionals in hospitals and clinics who rely on pulse oximetry data for clinical decision making and treatment adjustments. These facilities prefer medical grade devices that offer reliability accuracy and integration with other monitoring systems which supports sustained procurement and replacement demand. In addition hospitals and clinics often purchase pulse oximeters in large quantities including bedside monitors portable units and handheld devices to equip multiple departments which significantly contributes to higher market share compared to other end users. The expansion of hospital infrastructure globally particularly in emerging economies has further strengthened this segment as governments and private investors increase spending on healthcare facilities to meet growing population needs.
to Download this information in a PDF
North America leads the global pulse oximeter market due to its advanced healthcare infrastructure high disease awareness strong purchasing power and early adoption of medical technologies. The region has a high prevalence of chronic respiratory and cardiovascular diseases such as chronic obstructive pulmonary disease asthma heart failure and sleep apnea which require regular and continuous monitoring of blood oxygen levels. An aging population further contributes to demand as elderly patients are more prone to oxygen related complications and long term health conditions that necessitate frequent use of pulse oximeters. North America also has high awareness among both healthcare professionals and the general population regarding the importance of early diagnosis and preventive monitoring which drives routine use of pulse oximeters in clinical practice and home healthcare. The strong presence of leading medical device manufacturers in the United States and Canada supports continuous innovation availability and rapid commercialization of new pulse oximetry products. These companies invest heavily in research and development resulting in technologically advanced devices with improved accuracy connectivity and user friendliness which are readily adopted in the region. Another critical factor is high healthcare spending and strong reimbursement systems particularly in the United States which allow hospitals and clinics to invest in high quality medical grade monitoring equipment without major financial constraints. Regulatory frameworks in North America while stringent provide clear approval pathways which increase trust in device quality and safety and encourage adoption by healthcare providers. The rapid expansion of home healthcare and remote patient monitoring has also significantly boosted the pulse oximeter market in North America as patients increasingly manage chronic conditions at home using portable and connected devices.
to Download this information in a PDF
• March 2025: the introduction of iPulseOx has been announced by Smart Meter, a manufacturer of patient monitoring equipment. The first cell phone-connected pulse oximeter offers remote patient monitoring services for long-term diseases like heart disease and chronic obstructive pulmonary disease (COPD). • June 2024: Medtronic introduced a new handheld pulse oximeter featuring enhanced accuracy and connectivity options. Designed to improve patient monitoring, this device caters to the growing demand for portable and reliable health monitoring tools, particularly in home care and ambulatory settings. • June 2024: the release of the Oxy10 pulse oximeter was announced by DetelPro. The users of this product can determine the results with the aid of an LED display. The company's pulse oximeter portfolio was expanded throughout numerous hospitals and homecare facilities thanks to this product launch, which increased income for the company. • May 2024: Masimo partnered with Medable Inc. to incorporate its MightySat Rx pulse oximeter into decentralized clinical trials. This collaboration enables remote patient monitoring within clinical research, enhancing data collection and participant convenience. • February 2024: Masimo Corporation received FDA clearance for its MightySat Fingertip Pulse Oximeter, an advanced device designed for both clinical and personal use, featuring Signal Extraction Technology (SET®) for accurate readings even under motion and low perfusion conditions. • January 2024: a fingertip pulse oximeter that links to the TytoCare device via a cable to log test results to patients' EHRs and enable remote monitoring by clinicians was introduced by the telehealth business Tyto Care.

We are friendly and approachable, give us a call.